Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Insmed (INSM) Cash from Investing Activities (2016 - 2026)

Insmed's Cash from Investing Activities history spans 17 years, with the latest figure at $265.5 million for Q1 2026.

  • Quarterly Cash from Investing Activities rose 230.2% to $265.5 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $120.5 million through Mar 2026, up 115.1% year-over-year, with the annual reading at -$64.6 million for FY2025, 88.93% up from the prior year.
  • Cash from Investing Activities came in at $265.5 million for Q1 2026, down from $389.4 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $389.4 million in Q4 2025 to a low of -$1.0 billion in Q3 2024.
  • The 5-year median for Cash from Investing Activities is $20.3 million (2022), against an average of -$37.7 million.
  • The largest YoY upside for Cash from Investing Activities was 7207.71% in 2024 against a maximum downside of 14140.45% in 2024.
  • Insmed's Cash from Investing Activities stood at $20.3 million in 2022, then tumbled by 91.12% to $1.8 million in 2023, then soared by 7207.71% to $131.8 million in 2024, then soared by 195.55% to $389.4 million in 2025, then plummeted by 31.81% to $265.5 million in 2026.
  • Per Business Quant, the three most recent readings for INSM's Cash from Investing Activities are $265.5 million (Q1 2026), $389.4 million (Q4 2025), and -$762.2 million (Q3 2025).